CoronaryAtlas logo
CoronaryAtlas
Phosphatidylinositol 18:0/18:2
Pathway / Lipid retention & oxidation

Phosphatidylinositol 18:0/18:2

lipid

Phosphatidylinositol species in LDL track lipid remodeling under therapeutic intervention.

Pathway placement
Cascade stepLipid retention & oxidation
Confidencemedium
RationaleLDL lipidomic marker predicting statin response and lipid metabolism.
Druggability
Not assessed (no mapped human gene target).

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma (EDTA to limit oxidation)
Collection tube
K2/K3-EDTA (lavender-top) · Serum separator (gold/red-top, SST)
Method / principle
LC-MS/MS lipidomics (targeted or shotgun)
Reagent / substrate
Deuterated lipid-class internal standards; MS/MS transitions
Platform
LC-MS/MS
Turnaround · availability
Research · Research-only

Literature evidence(1)